TCL Archive Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint November 25, 2011
TCL Archive Facilities Survey Finrs $25 Million a Year for Five Years Needed From NCI By Year 1990 March 8, 1985
TCL Archive NCAB Member David Koch Gives $100 Million To MIT For New Cancer Research Institute. October 12, 2007